The short version of obesity research fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-08 and is reviewed periodically as new material appears.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; visual inspection |
| Solubility | Soluble in water and aqueous buffers | Depends on pH, purity, and counterion |
| Typical storage | -20 °C or below, desiccated | Protect from light; avoid repeated freeze-thaw after reconstitution |
| Common analytical method | Reversed-phase HPLC and mass spectrometry | Purity by HPLC; identity and mass by LC-MS or MALDI-TOF |
| Common synonyms | hGH fragment 176–191; AOD-9604 | Names vary in research and product labeling |
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
In addition, it continues to be common practice for men to shave their heads prior to embarking on a pilgrimage. The unibrow is considered a sign of beauty and attractiveness for women in Oman and for both genders in Tajikistan, often emphasized with kohl. In Middle Eastern societies, regular trimming or removal of female and male underarm hair and pubic hair has been considered proper personal hygiene, necessitated by local customs, for many centuries. Young girls and unmarried women, however, are expected to retain their body hair until shortly before marriage, when the whole body is depilated from the neck down. In China, body hair has long been regarded as normal, and even today women are confronted with far less social pressure to remove body hair. The same attitude exists in other countries in Asia. While hair removal has become routine for many of the continent's younger women, trimming or removing pubic hair, for instance, is not as common or popular as in the Western world, where both women and men may trim or remove all their pubic hair for aesthetic or sexual reasons. This custom can be motivated by reasons of potentially increased personal cleanliness or hygiene, heightened sensitivity during sexual activity, or the desire to take on a more exposed appearance or visual appeal, or to boost self-esteem when affected by excessive hair.
"In it, the distress, caused by thirst, to travellers, was alleviated by clusters of rays of the bright eyes of the girls; the rays that were shaming the currents of light, sweet and cold water charged with the strong fragrance of cardamom, clove, saffron, camphor and musk and flowing out of the pitchers (held in) the lotus-like hands of maidens (seated in) the beautiful water-sheds, made of the thick roots of vetiver mixed with marjoram, (and built near) the foot, covered with heaps of couch-like soft sand, of the clusters of newly sprouting mango trees, which constantly darkened the intermediate space of the quarters, and which looked all the more charming on account of the trickling drops of the floral juice, which thus caused the delusion of a row of thick rainy clouds, densely filled with abundant nectar."
== History == Rugby league started in Australia in the period 1907–08. The Australian Rugby Football League Board of Control was formed by the New South Wales Rugby League (NSWRL) and Queensland Rugby League (QRL) in December 1924 to administer the running of the national team. George Ball was the first secretary of the Board and John La Maro the first chairman. Prior to this time, the international rugby league was organised jointly by the NSWRL and the QRL. It was only after this time that the Australian team began to wear the now-familiar sporting colours of Green and Gold. Since 1924, rugby league bodies in all other states and territories became affiliated to the Board of Control and ARL. Until 1984 the ARFL Board of Control was effectively run by the NSWRL board, and many Queensland players and administrators throughout this period believed that the NSWRL used this power to the detriment of Queenslanders, especially with respect to national team selection. In 1986 the ARL was incorporated under the name Australian Rugby Football League Limited as a separate entity and Ken Arthurson was the first executive chairman of the new body. With national expansion of the competition implemented for the 1995 season the NSWRL passed control of the Winfield Cup competition to the ARL. Following Kerry Packer's announcement that his Optus Vision company owned both free-to-air and pay television broadcasting rights for the sport in Australia, News Corporation, controlled by Rupert Murdoch, undertook a bold bid to create a rival competition, Super League (Australia).
== Gochujang hot-taste unit == Gochujang hot-taste unit (GHU) is a unit of measurement for the pungency (spicy heat) of gochujang, based on the gas chromatography and the high-performance liquid chromatography of capsaicin and dihydrocapsaicin concentrations. Gochujang products are assigned to one of the five levels of spiciness: Mild, Slight Hot, Medium Hot, Very Hot, and Extreme Hot.
In contrast, it declined by approximately 2.2 percent in the placebo group (P=0.006). There is an emerging recognition of the role that diet and exercise can play in functionally limiting symptom progression. This is an area for further study, as there is no clear consensus guideline, but rather a body of case study work that suggests that appropriate physical activity can be an effective tool in managing disease progression. In one such study, side-alternating vibration training was used 3 times weekly for 15 weeks. The results showed that, at 15 weeks, the patient had a 116-meter (70%) improvement to their 6MWT, which is significant compared with the results from the aforementioned LOTS study.
Sources: en.wikipedia.org
== Early life == On March 21, 1906, John Davison Rockefeller III was born in New York City, New York. His parents were John Davison Rockefeller Jr. (1874–1960) and Abigail Greene "Abby" Aldrich (1874–1948), philanthropists. He had four younger brothers, Nelson, Winthrop, Laurance and David, and an elder sister, Abby. Through his father, he was a grandson of Standard Oil co-founder John Davison Rockefeller Sr. and schoolteacher Laura Celestia "Cettie" Spelman. Through his mother, he was a grandson of Senator Nelson Wilmarth Aldrich and Abigail Pearce Truman "Abby" Chapman. He received his preparatory education at the Browning School in New York City and the Loomis Chaffee School, Windsor, Connecticut, in 1925. He went to Princeton University where he received high honors in economics and graduated in 1929 with the degree of Bachelor of Science, choosing industrial relations as the subject of his senior thesis. His interest in industrial relations stemmed from the family's role in the Ludlow Massacre, in which strikebreakers and security guards killed women and children of miners striking against the Rockefeller-controlled Colorado Fuel and Iron Company. Rockefeller's father worked to restore the family's public reputation by championing industrial relations and the work of William Lyon Mackenzie King, a pioneer in the field. Commencing a lifelong commitment to international relations, he undertook a world tour after graduating from college, which concluded with assignments for the Institute of Pacific Relations conference in Japan.
Large batches of quantum dots may be synthesized via colloidal synthesis. Due to this scalability and the convenience of benchtop conditions, colloidal synthetic methods are promising for commercial applications.
There was a prosecutor that asked for an authorization for a prisoner to be freed that guaranteed that he knew where Rui Pedro was. The result: the prisoner went missing. Was not it. It's clear isn't it? They gave the prisoner credit cards. They gave the prisoner a car, gave money and (...) [everything went missing] If that was a lie I would be arrested, because it's easy to arrest journalists, working is hard.The journalist also critiqued the law for having allowed for Mendonça's grandfather to have the role that the Portuguese State had spending money on the Madeleine McCann case. However, Mendonça's grandfather spent his fortune falling for all kinds of scams while searching for the boy. He also questioned the PJ's high rate of success in solving missing children cases, but this one went through three teams of investigation without success. In another interview, he said that the Portuguese State should be on the defendant's bench in Dias' trial, for having left in the open who was, or were the defendants through the fourteen years, which could have affected the testimony of the witnesses in the court.
=== Vaccination === By 2006, China has successfully immunised 11.1 million children living in the country's poorest provinces against hepatitis B according to the Chinese health ministry, and the Global Alliance for Vaccines and Immunization (GAVI). However, China still has a long way to go before immunisation levels reach a percentage able to limit the spread of hepatitis B. China's health minister, Gao Qiang told a Beijing press conference that the project, while effective, has covered only one third of all children born in China since the project began in 2002. This does not mean the rest of China's children went unvaccinated. However, even within the project's target area, over one million newborns went unvaccinated each year because of access issues; health-care costs, lack of birth attendants, and the remoteness of their birthplaces, such as herder's huts, mountain villages, and remote farms. Until 2005, when a law banning the practice was passed, parents were charged fees for the administration of the vaccine. Even though the GAVI alliance (whose partners include UNICEF and the WHO), and Chinese government were providing the vaccine and one-use needles free of charge, health-care workers charged fees that parents were unwilling or unable to pay. Based on a 1992 epidemiological survey, the disease burden of those who are chronically infected with hepatitis B in China is estimated to be at 120 million, one third of the overall burden (360 million) as estimated by the WHO. China's national target is to reach greater than 85% vaccination.
Sources: en.wikipedia.org
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.
Mass spectrometry, such as LC-MS or MALDI-TOF, confirms the molecular mass and can reveal sequence-related impurities. Reversed-phase HPLC is used for purity, and peptide mapping or amino acid analysis can support sequence identity. No single method establishes every quality attribute.
No. AOD9604 is a short synthetic fragment of the hGH sequence, not the full 191-amino-acid hormone. It lacks the regions that mediate hGH receptor activation and growth-promoting effects. Products labeled as AOD9604 should not be assumed to have the same properties as hGH.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.